MAINTENANCE OF SKELETAL MUSCLES WHEN RECEIVING NEOADJUVANT CHEMOTHERAPY IMPROVES THE PROGNOSIS FOR PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Aoki, Maria
Naiki, Taku
Morikawa, Toshiharu
Isobe, Teruki
Gonda, Masakazu
Tomiyama, Nami
Shimizu, Nobuhiko
Noda, Yusuke
Nagai, Takashi
Banno, Rika
Nozaki, Satoshi
Etani, Toshiki
Ando, Ryosuke
Kawai, Noriyasu
Yasui, Takahiro
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP22-04
引用
收藏
页码：E296 / E297
页数：2
相关论文
共 50 条
  • [41] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Vasdev, N.
    Zargar, H.
    Fairey, A.
    Espiritu, P.
    Krabbe, L.
    Mongomery, J.
    Gandhi, N.
    Griffin, J.
    Yu, E.
    Campain, N.
    Xylinas, E.
    Horenblas, S.
    Yousef, D.
    Kassouf, W.
    Shariat, S.
    Aning, J.
    Wright, J.
    Holzbeierlein, J.
    Bivalacqua, T.
    Morgan, T.
    North, S.
    Borcas, D.
    Lotan, Y.
    Shah, J.
    Spiess, P.
    Van Rhijn, B.
    Daneshmand, S.
    Black, P.
    Thorpe, A. C.
    BJU INTERNATIONAL, 2014, 113 : 25 - 25
  • [42] DISEASE PROGRESSION DURING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
    Mossanen, Matthew
    JOURNAL OF UROLOGY, 2013, 189 (04): : E764 - E764
  • [43] Adverse Events During Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
    Salminen, Antti P.
    Perez, Ileana Montoya
    Klen, Riku
    Ettala, Otto O.
    Syvanen, Kari T.
    Elo, Laura L.
    Bostrom, Peter J.
    BLADDER CANCER, 2019, 5 (04) : 273 - 279
  • [44] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Zargar, Homayoun
    Espiritu, Patrick N.
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Gandhi, Nilay M.
    Griffin, Joshua
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Youssef, David
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Sridhar, Srikala S.
    McGrath, John S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Black, Peter C.
    EUROPEAN UROLOGY, 2015, 67 (02) : 241 - 249
  • [45] Neoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology
    Lin, James
    Whalen, Michael
    Holder, Dara
    Hruby, Gregory
    DeCastro, G. Joel
    McKiernan, James
    CANADIAN JOURNAL OF UROLOGY, 2013, 20 (02) : 6690 - 6695
  • [46] Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer
    Clark, Peter E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 821 - 830
  • [47] Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: Literature review
    Pectasides, D
    Pectasides, M
    Nikolaou, M
    EUROPEAN UROLOGY, 2005, 48 (01) : 60 - 68
  • [48] IMPLICATIONS OF NEOADJUVANT CHEMOTHERAPY ON COST AND OUTCOMES IN MUSCLE INVASIVE BLADDER CANCER
    Clinton, Timothy
    Woldu, Solomon
    Sanli, Oner
    Wang, Richard
    Gianni, Louis
    Raj, Ganesh
    Sagalowsky, Arthur
    Margulis, Vitaly
    Lotan, Yair
    JOURNAL OF UROLOGY, 2018, 199 (04): : E529 - E530
  • [49] Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Macleod, Liam C.
    Fam, Mina M.
    Yabes, Jonathan G.
    Hale, Nathan E.
    Turner, Robert M., II
    Lopa, Samia H.
    Gingrich, Jeffrey R.
    Borza, Tudor
    Skolarus, Ted A.
    Davies, Benjamin J.
    Jacobs, Bruce L.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 201 - +
  • [50] Neoadjuvant Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer
    Messing, Edward M.
    BLADDER CANCER, 2023, 9 (02) : 191 - 192
12345